Impact of psoriasis on health-related quality of life decreases over time: An 11-year prospective study

Journal of Investigative Dermatology

Volumn 126, Issue 7, 2006, Pages 1480-1489

  Unaeze, Jane ^a   Nijsten, Tamar ^b,c   Murphy, Amy ^d   Ravichandran, Caitlin ^d   Stern, Robert S ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SOCIAL ASPECT; STATISTICAL SIGNIFICANCE;

ADULT; AGE FACTORS; AGED; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PSORIASIS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; SICKNESS IMPACT PROFILE; TIME FACTORS;

EID: 33745194569     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700229     Document Type: Article

References (43)

1. Ashcroft DM, Li Wan PA, Williams HC, Griffiths CE (1998) Quality of life measures in psoriasis: a critical appraisal of their quality. J Clin Pharm Ther 23:391-8
2. Bendtsen P, Hornquist JO (1992) Change and status in quality of life in patients with rheumatoid arthritis. Qual Life Res 1:296-305
3. Cassileth BR, Lusk EJ, Strouse TB, Miller DS, Brown LL, Cross PA et al. (1984) Psychosocial status in chronic illness. A comparative analysis of six diagnostic groups. N Engl J Med 311:506-11
4. Choi J, Koo JY (2003) Quality of life issues in psoriasis. J Am Acad Dermatol 49:557-61
5. Dalgard F, Svensson A, Holm JO, Sundby J (2004) Self-reported skin morbidity among adults: associations with quality of life and general health in a Norwegian survey. J Invest Dermatol Symp Proc 9:120-5
6. de Arruda LH, De Moraes AP (2001) The impact of psoriasis on quality of life. Br J Dermatol 144(Suppl 58): 33-6
7. de Korte J, Sprangers MA, Mombers FM, Bos JD (2004) Quality of life in patients with psoriasis: a systematic literature review. J Invest Dermatol Symp Proc 9:140-7
8. Feldman SR, Gordon KB, Bala M, Evans R, Li S, Dooley LT et al. (2005) Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial. Br J Dermatol 152:954-60
9. Feldman SR, Menter A, Koo JY (2004) Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis. Br J Dermatol 150:317-26
10. Fortune DG, Richards HL, Kirby B, McElhone K, Main CJ, Griffiths CE (2004) Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being. Br J Dermatol 151:1219-26
11. Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ (2004) Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 51:704-8
12. Groves T (1992) What the changes mean. BMJ 305:1489-90
13. Gupta MA, Gupta AK (1995) Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol 34:700-3
14. Howard GS, Dailey PR, Gulanick NA (1979) The feasibility of informed pretests in attenuating response shift bias. Appl Psychol Meas 3:1-23
15. Jobling RG (1976) Psoriasis - a preliminary questionnaire study of sufferers' subjective experience. Clin Exp Dermatol 1:233-6
16. Koo J (1996) Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 14:485-96
17. Krause NM, Jay GM (1994) What do global self-rated health items measure? Med Care 32:930-42
18. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T (2001) The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 137:280-4.
19. Liang KY, Zeger SL (1986) Longitudinal data analysis using generalized linear models. Biometrika 73:13-22
20. Mazzotti E, Picardi A, Sampogna F, Sera F, Pasquini P, Abeni D, IMPROVE Study Group (2003) Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis. Br J Dermatol 149:318-22
21. McKenna KE, Stern RS (1997) The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort. J Am Acad Dermatol 36:388-94
22. McNutt LA, Wu C, Xue X, Hafner JP (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157:940-3
23. Melski JW, Tanenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL (1977) Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol 68:328-35
24. Nijsten T, Rolstad T, Feldman SR, Stern RS (2005) Members of the National Psoriasis Foundation: more extensive disease and better informed about treatment options. Arch Dermatol 141:19-26
25. Nijsten T, Unaeze J, Stern RS (2006) Refinement and reduction of the Impact of Psoriasis Questionnaire: Classical Test Theory vs Rasch Analysis. Br J Dermatol. (in press)
26. Ramsay B, O'Reagan M (1988) A survey of the social and psychological effects of psoriasis. Br J Dermatol 118:195-201
27. Rapp SR, Lyn Exum M, Reboussin DM, Feldman SR, Fleischer A, Clark A (1997) The physical, psychological and social impact of psoriasis. Br J Health Psychol 2:525-53
28. Roenigk RK, Roenigk HH Jr (1978) Sex differences in the psychological effects of psoriasis. Cutis 21:529-33
29. Salek MS, Finlay AY, Lewis JJ, Sumner MI (2004) Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral). Qual Life Res 13:91-5
30. Sampogna F, Sera F, Abeni D (2004) Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 122:602-7
31. SAS Institute (2005) SAS System. Cary, NC: SAS Institute. Inc.
32. Scharloo M, Kaptein AA, Weinman J, Bergman W, Vermeer BJ, Rooijmans HG (2000) Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol 142:899-907
33. Schmid-Ott G, Kunsebeck HW, Jager B, Sittig U, Hofste N, Ott R et al. (2005) Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Derm Venereol 85:27-32
34. STATA Corp (2004) STATA 8.0 Software. College Station, TX: Stata Corp
35. Steptoe A, Marmot M (2003) Burden of psychosocial adversity and vulnerability in middle age: associations with biobehavioral risk factors and quality of life. Psychosom Med 65:1029-37
36. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T (2004) Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Invest Dermatol Symp Proc 9:136-9
37. Tennant A, McKenna SP, Hagell P (2004) Application of Rasch analysis in the development and application of quality of life instruments. Value Health 7(Suppl 1):S22-6
38. van de Kerkhof PC (2004) The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial. Br J Dermatol 151:663-8
39. Vensel E, Hilley T, Trent J, Taylor JR, Kirsner RS, Kerdel FA et al. (2000) Sustained improvement of the quality of life of patients with psoriasis after hospitalization. J Am Acad Dermatol 43:858-60
40. Wahl A, Moum T, Hanestad BR, Wiklund I (1999) The relationship between demographic and clinical variables, and quality of life aspects in patients with psoriasis. Qual Life Res 8:319-26
41. Wahl AK, Gjengedal E, Hanestad BR (2002) The bodily suffering of living with severe psoriasis: in-depth interviews with 22 hospitalized patients with psoriasis. Qual Health Res 12:250-61
42. Wahl AK, Mork C, Cooper BA, Padilla G (2005) No long-term changes in psoriasis severity and quality of life following climate therapy. J Am Acad Dermatol 52:699-701
43. Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mork C et al. (2002) Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol 146:1006-16